Jeffrey Scott Riley serves as Executive at Synthetic Biologics, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Scott Riley has executed 6 insider transactions totaling $129.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 28, 2024 involved purchasing 30,000 shares valued at $115.8K.
Jeffrey Scott Riley currently holds 30,000 shares of Synthetic Biologics, Inc. (SYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Scott Riley has been a net buyer of SYN stock. They have purchased $129.4K and sold $0 worth of shares.
Jeffrey Scott Riley's most recent insider trade was on Mar 28, 2024, when they purchased 30,000 shares at $3.86 per share.
Get notified when new Form 4 filings are submitted
| $1.71 |
| Discretionary |
| Jan 7, 2013 | SYN | $492 | Purchase | 2,895 | $0.17 | Discretionary |
| Jan 3, 2013 | SYN | $4.9K | Purchase | 2,800 | $1.75 | Discretionary |
| Jan 3, 2013 | SYN | $3.4K | Purchase | 2,000 | $1.71 | Discretionary |
| Jan 2, 2013 | SYN | $4.8K | Purchase | 2,700 | $1.78 | Discretionary |